CanPursue

Research

  • Search
  • Opportunities
  • Buyers
  • Suppliers
  • Contracts
  • Awards

Intelligence

  • OverviewAccount required
  • WatchlistsAccount required
  • PipelineAccount required
  • IntelligenceAccount required
Create free account

Sign in

⌘K
ENFR
Emergent BioDefense Operations Lansing Government Contracts in Canada · CanPursue
Suppliers

Emergent BioDefense Operations Lansing

Also known as: Emergent BioDefense Operations LansingObserved
Watch
Observed value
$209.3M
Contracts
7
Awards
2
Buyers
1
OverviewContractsAwardsBuyersCategoriesActivity
  • Tembexa (brincidofovir) Smallpox antiviralAwarded, Feb 25, 2026
  • Tembexa (brincidofovir) Smallpox antiviralAwarded, Feb 25, 2026
  • Tembexa (brincidofovir) Smallpox antiviralAwarded, Feb 25, 2026
  • Amend 010 - BioThrax Vaccine - Emergent BioDefense Operations Lansing LLCAwarded, Oct 25, 2019
  • Amend 009 - BioThrax Vaccine - Emergent BioDefense Operations Lansing LLCAwarded, Oct 25, 2019
  • Amend 008 - BioThrax Vaccine - Emergent BioDefense Operations Lansing LLCAwarded, Oct 25, 2019
  • Amend 005 - BioThrax Vaccine - Emergent BioDefense Operations Lansing LLCAwarded, Oct 25, 2019
  • Amend 004 - BioThrax Vaccine - Emergent BioDefense Operations Lansing LLCAwarded, Oct 25, 2019
  • Amend 010 - BioThrax Vaccine - Emergent BioDefense Operations Lansing LLCAwarded, Oct 25, 2019